List of Tables
Table 1. Global Nicotinamide Riboside Supplements Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Nicotinamide Riboside Supplements Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Nicotinamide Riboside Supplements Market Competitive Situation by Manufacturers in 2024
Table 4. Global Nicotinamide Riboside Supplements Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Nicotinamide Riboside Supplements Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Nicotinamide Riboside Supplements Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Nicotinamide Riboside Supplements Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Nicotinamide Riboside Supplements Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Nicotinamide Riboside Supplements, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nicotinamide Riboside Supplements, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nicotinamide Riboside Supplements, Product Type & Application
Table 12. Global Key Manufacturers of Nicotinamide Riboside Supplements, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nicotinamide Riboside Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Riboside Supplements as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nicotinamide Riboside Supplements Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Nicotinamide Riboside Supplements Sales by Region (2020-2025) & (K Units)
Table 18. Global Nicotinamide Riboside Supplements Sales Market Share by Region (2020-2025)
Table 19. Global Nicotinamide Riboside Supplements Sales by Region (2026-2031) & (K Units)
Table 20. Global Nicotinamide Riboside Supplements Sales Market Share by Region (2026-2031)
Table 21. Global Nicotinamide Riboside Supplements Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Nicotinamide Riboside Supplements Revenue Market Share by Region (2020-2025)
Table 23. Global Nicotinamide Riboside Supplements Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Nicotinamide Riboside Supplements Revenue Market Share by Region (2026-2031)
Table 25. North America Nicotinamide Riboside Supplements Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Nicotinamide Riboside Supplements Sales by Country (2020-2025) & (K Units)
Table 27. North America Nicotinamide Riboside Supplements Sales by Country (2026-2031) & (K Units)
Table 28. North America Nicotinamide Riboside Supplements Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Nicotinamide Riboside Supplements Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Nicotinamide Riboside Supplements Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Nicotinamide Riboside Supplements Sales by Country (2020-2025) & (K Units)
Table 32. Europe Nicotinamide Riboside Supplements Sales by Country (2026-2031) & (K Units)
Table 33. Europe Nicotinamide Riboside Supplements Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Nicotinamide Riboside Supplements Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Nicotinamide Riboside Supplements Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Nicotinamide Riboside Supplements Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Nicotinamide Riboside Supplements Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Nicotinamide Riboside Supplements Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Nicotinamide Riboside Supplements Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Nicotinamide Riboside Supplements Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Nicotinamide Riboside Supplements Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Nicotinamide Riboside Supplements Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Nicotinamide Riboside Supplements Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nicotinamide Riboside Supplements Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Nicotinamide Riboside Supplements Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Nicotinamide Riboside Supplements Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Nicotinamide Riboside Supplements Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Nicotinamide Riboside Supplements Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Nicotinamide Riboside Supplements Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Nicotinamide Riboside Supplements Sales (K Units) by Type (2020-2025)
Table 51. Global Nicotinamide Riboside Supplements Sales (K Units) by Type (2026-2031)
Table 52. Global Nicotinamide Riboside Supplements Sales Market Share by Type (2020-2025)
Table 53. Global Nicotinamide Riboside Supplements Sales Market Share by Type (2026-2031)
Table 54. Global Nicotinamide Riboside Supplements Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Nicotinamide Riboside Supplements Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Nicotinamide Riboside Supplements Revenue Market Share by Type (2020-2025)
Table 57. Global Nicotinamide Riboside Supplements Revenue Market Share by Type (2026-2031)
Table 58. Global Nicotinamide Riboside Supplements Price (US$/Unit) by Type (2020-2025)
Table 59. Global Nicotinamide Riboside Supplements Price (US$/Unit) by Type (2026-2031)
Table 60. Global Nicotinamide Riboside Supplements Sales (K Units) by Application (2020-2025)
Table 61. Global Nicotinamide Riboside Supplements Sales (K Units) by Application (2026-2031)
Table 62. Global Nicotinamide Riboside Supplements Sales Market Share by Application (2020-2025)
Table 63. Global Nicotinamide Riboside Supplements Sales Market Share by Application (2026-2031)
Table 64. Global Nicotinamide Riboside Supplements Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Nicotinamide Riboside Supplements Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Nicotinamide Riboside Supplements Revenue Market Share by Application (2020-2025)
Table 67. Global Nicotinamide Riboside Supplements Revenue Market Share by Application (2026-2031)
Table 68. Global Nicotinamide Riboside Supplements Price (US$/Unit) by Application (2020-2025)
Table 69. Global Nicotinamide Riboside Supplements Price (US$/Unit) by Application (2026-2031)
Table 70. Thorne Company Information
Table 71. Thorne Description and Business Overview
Table 72. Thorne Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Thorne Nicotinamide Riboside Supplements Product
Table 74. Thorne Recent Developments/Updates
Table 75. Codeage Company Information
Table 76. Codeage Description and Business Overview
Table 77. Codeage Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Codeage Nicotinamide Riboside Supplements Product
Table 79. Codeage Recent Developments/Updates
Table 80. ProHealth Longevity Company Information
Table 81. ProHealth Longevity Description and Business Overview
Table 82. ProHealth Longevity Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. ProHealth Longevity Nicotinamide Riboside Supplements Product
Table 84. ProHealth Longevity Recent Developments/Updates
Table 85. ChromaDex Company Information
Table 86. ChromaDex Description and Business Overview
Table 87. ChromaDex Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. ChromaDex Nicotinamide Riboside Supplements Product
Table 89. ChromaDex Recent Developments/Updates
Table 90. HPN Nutraceuticals Company Information
Table 91. HPN Nutraceuticals Description and Business Overview
Table 92. HPN Nutraceuticals Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. HPN Nutraceuticals Nicotinamide Riboside Supplements Product
Table 94. HPN Nutraceuticals Recent Developments/Updates
Table 95. Cytoplan Company Information
Table 96. Cytoplan Description and Business Overview
Table 97. Cytoplan Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Cytoplan Nicotinamide Riboside Supplements Product
Table 99. Cytoplan Recent Developments/Updates
Table 100. solodate Company Information
Table 101. solodate Description and Business Overview
Table 102. solodate Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. solodate Nicotinamide Riboside Supplements Product
Table 104. solodate Recent Developments/Updates
Table 105. Orgabay Company Information
Table 106. Orgabay Description and Business Overview
Table 107. Orgabay Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Orgabay Nicotinamide Riboside Supplements Product
Table 109. Orgabay Recent Developments/Updates
Table 110. Rossylla Company Information
Table 111. Rossylla Description and Business Overview
Table 112. Rossylla Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Rossylla Nicotinamide Riboside Supplements Product
Table 114. Rossylla Recent Developments/Updates
Table 115. Life Extension Company Information
Table 116. Life Extension Description and Business Overview
Table 117. Life Extension Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Life Extension Nicotinamide Riboside Supplements Product
Table 119. Life Extension Recent Developments/Updates
Table 120. Aesticum Company Information
Table 121. Aesticum Description and Business Overview
Table 122. Aesticum Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Aesticum Nicotinamide Riboside Supplements Product
Table 124. Aesticum Recent Developments/Updates
Table 125. ProHealth Company Information
Table 126. ProHealth Description and Business Overview
Table 127. ProHealth Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. ProHealth Nicotinamide Riboside Supplements Product
Table 129. ProHealth Recent Developments/Updates
Table 130. NOW Company Information
Table 131. NOW Description and Business Overview
Table 132. NOW Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. NOW Nicotinamide Riboside Supplements Product
Table 134. NOW Recent Developments/Updates
Table 135. Double Wood Supplements Company Information
Table 136. Double Wood Supplements Description and Business Overview
Table 137. Double Wood Supplements Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Double Wood Supplements Nicotinamide Riboside Supplements Product
Table 139. Double Wood Supplements Recent Developments/Updates
Table 140. aSquared Nutrition Company Information
Table 141. aSquared Nutrition Description and Business Overview
Table 142. aSquared Nutrition Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. aSquared Nutrition Nicotinamide Riboside Supplements Product
Table 144. aSquared Nutrition Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Nicotinamide Riboside Supplements Distributors List
Table 148. Nicotinamide Riboside Supplements Customers List
Table 149. Nicotinamide Riboside Supplements Market Trends
Table 150. Nicotinamide Riboside Supplements Market Drivers
Table 151. Nicotinamide Riboside Supplements Market Challenges
Table 152. Nicotinamide Riboside Supplements Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Nicotinamide Riboside Supplements
Figure 2. Global Nicotinamide Riboside Supplements Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nicotinamide Riboside Supplements Market Share by Type: 2024 & 2031
Figure 4. Capsule Product Picture
Figure 5. Liquid Product Picture
Figure 6. Softgel Product Picture
Figure 7. Global Nicotinamide Riboside Supplements Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Nicotinamide Riboside Supplements Market Share by Application: 2024 & 2031
Figure 9. Online Sales
Figure 10. Offline Sales
Figure 11. Global Nicotinamide Riboside Supplements Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Nicotinamide Riboside Supplements Market Size (2020-2031) & (US$ Million)
Figure 13. Global Nicotinamide Riboside Supplements Sales (2020-2031) & (K Units)
Figure 14. Global Nicotinamide Riboside Supplements Average Price (US$/Unit) & (2020-2031)
Figure 15. Nicotinamide Riboside Supplements Report Years Considered
Figure 16. Nicotinamide Riboside Supplements Sales Share by Manufacturers in 2024
Figure 17. Global Nicotinamide Riboside Supplements Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Nicotinamide Riboside Supplements Players: Market Share by Revenue in Nicotinamide Riboside Supplements in 2024
Figure 19. Nicotinamide Riboside Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Nicotinamide Riboside Supplements Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Nicotinamide Riboside Supplements Sales Market Share by Country (2020-2031)
Figure 22. North America Nicotinamide Riboside Supplements Revenue Market Share by Country (2020-2031)
Figure 23. United States Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Nicotinamide Riboside Supplements Sales Market Share by Country (2020-2031)
Figure 26. Europe Nicotinamide Riboside Supplements Revenue Market Share by Country (2020-2031)
Figure 27. Germany Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Nicotinamide Riboside Supplements Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Nicotinamide Riboside Supplements Revenue Market Share by Region (2020-2031)
Figure 34. China Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Nicotinamide Riboside Supplements Sales Market Share by Country (2020-2031)
Figure 42. Latin America Nicotinamide Riboside Supplements Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Nicotinamide Riboside Supplements Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Nicotinamide Riboside Supplements Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Nicotinamide Riboside Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Nicotinamide Riboside Supplements by Type (2020-2031)
Figure 53. Global Revenue Market Share of Nicotinamide Riboside Supplements by Type (2020-2031)
Figure 54. Global Nicotinamide Riboside Supplements Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Nicotinamide Riboside Supplements by Application (2020-2031)
Figure 56. Global Revenue Market Share of Nicotinamide Riboside Supplements by Application (2020-2031)
Figure 57. Global Nicotinamide Riboside Supplements Price (US$/Unit) by Application (2020-2031)
Figure 58. Nicotinamide Riboside Supplements Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
